Rivercell raises $25 million to build AI model for human cells
French biotech startup Rivercell has closed a $25 million seed round to develop an AI that can analyze and predict the behavior of human cells. The goal is to speed up drug discovery by modeling how cells respond to different treatments. The funding was led by Sofinnova Partners. Rivercell’s system aims to map cell states, but the approach is still early days.
- Rivercell is based in Paris
- $25 million seed round led by Sofinnova Partners
- AI system will model and predict human cell behavior
- Company aims to accelerate drug discovery
Sources covering this
More in Startups
Mecka AI raises $60 million to expand robot training data
Mecka AI, a startup creating real-world data to help robots learn, just secured $60 million in funding.
Chandigarh University sets up quantum startup investment pipeline
Chandigarh University’s deep-tech incubator, CUBIC, has struck a deal with Indian venture fund 247VC to streamline investment and…
Endeavor Catalyst closes $320M fund for global founders
Endeavor Catalyst has secured $320 million for its fifth fund, bringing total assets under management to over $850 million.
Lumio raises $12M to expand smart electronics lineup
Lumio, an Indian startup making smart TVs, projectors, and speakers, just raised $12 million in Series A funding led by Blume Ventures.